Document Detail


Anticoagulants in pregnancy.
MedLine Citation:
PMID:  8309994     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pregnancy is associated with a prethrombotic state. Pulmonary embolism is the major cause of maternal mortality. Anticoagulant prophylaxis and therapy are therefore commonplace in pregnant women. Those with inherited and acquired thrombophilic conditions are at increased risk and special considerations arise in management. Heparin has recently become the favoured anticoagulant drug in pregnancy. Its use carries risks of osteopaenia and thrombocytopaenia, as well as haemorrhage, in the mother. Warfarin is teratogenic and may also cause haemorrhagic complications in mother and fetus. Few clinical trial data exists for guidance on optimal anticoagulant regimes during pregnancy and the puerperium and details of management will depend upon the personal preferences of patient and clinician, after due consideration of the perceived risks and benefits in the individual clinical situation.
Authors:
M Greaves
Related Documents :
15316434 - Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism...
12763494 - Inherited thrombophilia and pregnancy loss.
14597244 - Factor v leiden, prothrombin 20210g --> a, methylenetetrahydrofolate reductase 677c -->...
12780794 - Venous thromboembolism associated with the management of acute thrombotic thrombocytope...
17081184 - Is elective single embryo transfer a cost-effective alternative to double embryo transfer?
15003034 - Pregnancy exposure registries.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pharmacology & therapeutics     Volume:  59     ISSN:  0163-7258     ISO Abbreviation:  Pharmacol. Ther.     Publication Date:  1993 Sep 
Date Detail:
Created Date:  1994-03-16     Completed Date:  1994-03-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7905840     Medline TA:  Pharmacol Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  311-27     Citation Subset:  IM    
Affiliation:
Department of Haematology, Royal Hallamshire Hospital, Sheffield, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / etiology
Anticoagulants / adverse effects,  therapeutic use*
Female
Heparin / adverse effects
Humans
Postpartum Period
Pregnancy
Pregnancy Complications, Cardiovascular / drug therapy*
Thromboembolism / drug therapy*,  prevention & control
Warfarin / adverse effects
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Modelling of the passage of drugs into milk.
Next Document:  Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biologi...